Early Response to Vunakizumab at Week 2 Predicts Favourable Long‐Term Efficacy in Patients With Moderate‐To‐Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III , Randomised Controlled Trial

This study was a post hoc analysis of a Phase III trial (NCT04839016), which aims to investigate whether early response to vunakizumab can predict long‐term efficacy in plaque psoriasis patients. A total of 461 plaque psoriasis patients receiving vunakizumab treatment were included for analysis. Ear...

Full description

Saved in:
Bibliographic Details
Published in:Immunology 2026-01
Main Authors: Sun, Xiaoying, Zhang, Yaohua, Lu, Xiya, Tang, Suwei, Chen, Fujuan, Sun, Ziwen, Li, Xin
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!